1142
J. Ma et al. / Phytochemistry 65 (2004) 1137–1143
1
(7), 137 (100). For H and 13C NMR spectral data see
Table 1.
(CD3)2CO, TMS): d 1.57 (2H, m, H-4), 1.70 (4H, m, H-2
and H-6), 2.55 (2H, dt, J=13.6 and 7.6 Hz, H-1a and
H-7a), 2.68 (2H, dt, J=13.6 and 8.0 Hz, H-1b and H-
7b), 3.80 (6H, s, 30-OMe and 300-OMe), 3.88 (2H, m, H-3
and H-5), 6.63 (2H, d, J=8.0 Hz, H-60 and H-600), 6.71
(2H, d, J=8.0 Hz, H-50 and H-500), 6.80 (2H, s, H-20 and
H-200). 13C NMR (100 MHz, (CD3)2CO, TMS): ꢁ 32.4
3.6. (3R,5S)-3,5-dihydroxy-1-(4-hydroxy-3,5-dimethoxy-
phenyl)-7-(4-hydroxy-3-methoxyphenyl)heptane (1c):
Colorless oil; [ꢀ]D24 0 (c 0.55, CHCl3); [M+NH4]+ m/z
424.2326 for C22H34NO7 (Calc. 424.2330). IR ꢂKmaBxr cmꢁ1
0
:
(C-1and C-7), 40.9 (C-2 and C-6), 44.7 (C-4), 56.2 (3 -
3412 (OH), 1726 (CO), 1612, 1517 (Ar). EI-MS m/z (rel.
int.): 406 (15) [M]+, 388 (3), 181 (12), 168 (86), 137 (83),
43 (100). For 1H and 13C NMR spectral data see Table 1.
OMe and 300-OMe), 68.3 (C-3 and C-5), 112.9 (C-20 and
C-200), 115.6 (C-50 and C-500), 121.5 (C-60 and C-600),
134.8 (C-10 and C-100), 145.3 (C-40 and C-400), 148.1 (C-30
and C-300). EIMS m/z (rel. int.): 376 (10) [M]+, 358 (7),
190 (6), 179 (5), 163 (6), 150 (8), 137 (100).
3.7. (5S)-5-acetoxy-1,7-bis(4-hydroxy-3-methoxy-
phenyl)heptan-3-one (2a)
3.11. Acetylation of 2a
Colorless oil; [ꢀ]2D4 +3.0o (c 0.60, CHCl3); [M+NH4]+
m/z 434.2164 for C23H32NO7 (Calc. 434.2173). IR ꢂ
KBr
max
Compound 2a (2 mg) was acetylated with Ac2O–pyr-
idine at room temperature to give 2f whose spectral data
were identical to those of the acetylation product of
hexahydrocurcumin (2e) under the same experimental
conditions. (5S)-5-acetoxy-1,7-bis(4-acetoxy-3- methoxy-
phenyl)-heptan-3-one (2f): Colorless oil. [ꢀ]2D5 ꢁ2.0ꢀ (c
0.18, CHCl3). [M+NH4]+ m/z 518.2387 for C27H32O9
cmꢁ1: 3434 (OH), 1717 (CO), 1606, 1516 (Ar). EI-MS
m/z (rel. int.): 416 (6) [M]+, 356 (6), 177 (3), 163 (4), 150
(9), 137 (100). For HMBC correlations see Fig. 2. For
1H and 13C NMR spectral data see Table 1.
3.8. 5-Hydroxy-1-(3,4-dihydroxy-5-methoxyphenyl)-7-
(4-hydroxy-3-methoxyphenyl)heptan-3- one (2b) and
5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-
1
(calc. 518.2385). H NMR (400 MHz, CDCl3, TMS): ꢁ
1.90 (2H, dt, J=14.1 and 7.5 Hz, H-6), 1.99 (3H, s, 5-
OAc), 2.30 (6H, s, 40-OAc and 400-OAc), 2.59 (2H, dt,
J=11.7 and 5.7 Hz, H-7), 2.63 (1H, dd, J=13.5 and 7.5
Hz, H-4a), 2.73 (2H, t, J=6.9 Hz, H-2), 2.74 (1H, dd,
J=11.7 and 4.8 Hz, H-4b), 2.86 (2H, t, J=6.6 Hz, H-1),
3.80 (3H, s, 30-OMe), 3.82 (3H, s, 300-OMe), 5.28 (1H,
quint, J=6.3 Hz, H-5), 6.73 (2H, d, J=7.5 Hz, H-50 and
H-500), 6.78 (2H, s, H-20 and H-200), 6.92 (2H, d, J=6.6
Hz, H-60 and H-600). EI-MS m/z (rel. int.): 500 (2) M+,
458 (18), 398 (16), 356 (22), 137 (100).
(3,4-dihydroxy-5-methoxyphenyl)heptan-3-one (2c)
Colorless oil. [M+Na]+ m/z 413.15708 for C21H26O7Na
KBr
max
(calc. 413.15762). IR ꢂ
cmꢁ1: 3411 (OH), 1701 (CO),
1607, 1518 (Ar). EI-MS m/z (rel. int.): 390 (11) [M]+,
372 (3), 179 (8), 167 (11), 153 (61), 137 (100); For
HMBC correlations, see Fig. 2. For H and 13C NMR
spectral data see Table 1.
1
3.9. Acetylation of 1b
3.12. 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-7-
(3,4-dihydroxyphenyl)heptan-3-one (2d)
Compound 1b (1mg) was acetylated with Ac O–pyr-
2
idine at room temperature to give 1h whose spectral
ꢀ
data were identical to those reported in the literature
Colorless needles; m.p. 163–164 C; [ꢀ]1D6 0 (c 0.74,
ꢀ
1
(Kikuzaki et al., 1991a). [ꢀ]2D5 0 (c 0.25, CHCl3). H
NMR (400 MHz, CDCl3, TMS): ꢁ 1.90–1.81 (6H, m, H-
2, H-4 and H-6), 2.02 (6H, s, 3-OAc, 5-OAc), 2.30 (6H,
s, 40-OAc and 400-OAc), 2.60 (4H, t, J=7.8 Hz, H-1and
H-7), 3.82 (6H, s, 30-OMe and 300-OMe), 5.03 (2H, m,
H-3 and H-5), 6.74 (2H, d, J=7.5 Hz, H-50 and H-500),
6.78 (2H, s, H-20 and H-200), 6.93 (2H, dd, J=8.1and 1.8
Hz, H-60 and H-600). EIMS m/z (rel. int.): 544 (0.3)
[M]+, 502 (6), 442 (6), 400 (7), 340 (7), 190 (15), 163 (13),
150 (9), 137 (87), 43 (100).
EtOH). [M+NH4]+ m/z 378.1923 for C20H24O6NH4
KBr
max
(calc. 378.1911). IR ꢂ
cmꢁ1: 3392 (OH), 1703 (CO),
1606, 1518 (Ar). 1H NMR (400 MHz, (CD3)2CO,TMS):
ꢁ 1.66 (2H, dt, J=14.4 and 7.2 Hz, H-6), 2.48 (1H, dt,
J=13.6 and 8.1 Hz, H-7a), 2.56 (2H, d, J=6.0 Hz, H-
4), 2.61(1H, dt, J=14.4 and 8.0 Hz, H-7b), 2.74 (2H, t,
J=6.8 Hz, H-1), 2.76 (2H, t, J=6.8 Hz, H-2), 3.79 (3H,
s, 30-OMe), 4.01(1H, quint, J=6.0 Hz, H-5), 6.50 (1H,
d, J=8.8 Hz, H-600), 6.62 (1H, d, J=8.4 Hz, H-60), 6.67
(1H, s, H-200), 6.70 (2H, d, J=7.6 Hz, H-50 and H-500),
6.80 (1H, s, H-20). 13C NMR (100 MHz, (CD3)2CO,
TMS): d 29.4 (C-1), 31.8 (C-7), 40.2 (C-6), 45.9 (C-2),
50.8 (C-4), 56.2 (30-OMe), 67.6 (C-5), 112.9 (C-20), 115.6
(C-500), 115.8 (C-50), 116.2 (C-200), 120.3 (C-600), 121.4
(C-60), 133.6 (C-10), 134.7 (C-100), 143.7 (C-300), 145.5
(C-40), 145.6 (C-400), 148.2 (C-30), 210.3 (C-3). EI-MS m/
z (rel. int.): 360 (6) [M]+, 248 (8), 150 (16), 137 (100).
3.10. Hydrolysis of 1a
Compound 1a (2 mg) was hydrolyzed with KOH/
MeOH to give 1f whose spectral data were identical to
those reported in the literature (Kikuzaki et al., 1991a).
[ꢀ]2D7 ꢁ7.0ꢀ (c 0.18, CHCl3). 1H NMR (400 MHz,